Please login to the form below

Not currently logged in
Email:
Password:

Zoetis

This page shows the latest Zoetis news and features for those working in and with pharma, biotech and healthcare.

Pfizer mulling product sale to streamline ops; sources

Pfizer mulling product sale to streamline ops; sources

unit Zoetis to deal with accretion and dilution.

Latest news

More from news
Approximately 2 fully matching, plus 24 partially matching documents found.

Latest Intelligence

  • Pharma deals during November 2014 Pharma deals during November 2014

    form of Zoetis who this month acquired Abbott's animal health business for $255m. ... Bill Ackman, a Valeant investor, now owns 8.5% of Zoetis, which may pave the way for a potential deal.

  • Pharma deals during April 2014 Pharma deals during April 2014

    spot in terms of sales, second only to Zoetis.

  • Pharma deals during January 2014 Pharma deals during January 2014

    Several major pharma firms are deciding where to focus their business interests with Pfizer spinning out Zoetis for its animal health interests and Abbott doing the same for its pharma business,

  • Pharma deals during December 2012 Pharma deals during December 2012

    2012. The next major event in the animal health deal calendar will probably be the IPO of Pfizer's animal health business (named in the IPO documents as Zoetis) which had

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Six Degrees Medical Consulting

For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics